Sage Therapeutics (SAGE) PT Lowered to $121 at Stifel, Following Earnings

February 24, 2021 1:27 PM EST
Get Alerts SAGE Hot Sheet
Price: $74.37 --0%

Rating Summary:
    17 Buy, 9 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 10 | New: 10
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Stifel analyst Paul Matteis lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $121.00 (from $123.00) while maintaining a Buy rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

Stifel, Earnings